Lanean...
A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers
In a double-blind placebo controlled trial intranasal NPC 567, a bradykinin antagonist, failed to alleviate the symptoms of experimental rhinovirus colds. Indeed, there was evidence that the drug enhanced the symptoms although no irritant effect was detected on the uninfected nasal mucosa.
Gorde:
| Argitaratua izan da: | Antiviral Res |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Published by Elsevier B.V.
1990
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7134172/ https://ncbi.nlm.nih.gov/pubmed/1965113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/0166-3542(90)90052-9 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|